Danaher Corporation (DHR): Executive Vice President sold ~$484K

~$484K

Approx. value · 2,100 sh @ $230.62

22K

Holds after · shares reported

Traded

Nov 9, 2026

Filed

Nov 10, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Aug 31, 2026CongressDisclosed sale of DHR — reported range $15,001 - $50,000
2. Sep 2, 2026CongressDisclosed partial sale of DHR — reported range $1,001 - $15,000
3. Sep 21, 2026FDAFDA device clearance: Access NT-proBNP
4. Sep 21, 2026FDARecall: ROTOR ASSY-SW41, Reference Number 331362, when the rotors are installed in the following centrifuges: Optima XPN-100 (Model Numbers A99846 and A94469), Optima…
5. Sep 21, 2026FDARecall: ROTOR ASSY-SW40, Reference Number 331302, when the rotors are installed in the following centrifuges: Optima XPN-100 (Model Numbers A99846 and A94469), Optima…
6. Sep 25, 2026FDAFDA device clearance: Xpert Respiratory Panel
7. Oct 9, 2026Company filing · Form 8-K · Executive change, Other newsChanged a top executive or board member, and reported other company news“On October 9, 2026, the Board of Directors (the “Board”) of Danaher Corporation (the “Company” or “Danaher”) increased the size of the Board to thirteen members and appointed Daniel L. Comas and Robert M. Hershberg to the Board, in each case effective immediately.”
8. Oct 19, 2026FDAFDA device clearance: Access MeMed BV
9. Oct 20, 2026FDAFDA device clearance: Access BNP II
10. Oct 21, 2026Company filing · Form 8-K · ResultsReported its results
11. Oct 28, 2026Insider · 2 peopleInsiders: 4 sales (~$8.8M)
12. Oct 30, 2026FDAFDA device clearance: Xpert® Hemorrhagic Fever Panel
13. Nov 5, 20265% stakeFMR LLC reported a passive stake (13G) of 5.6%
14. Nov 9, 2026 · this disclosureInsiderOfficer sold ~$484K of DHR shares in the open market

What came next

1. Nov 9, 2026InsiderOfficer sold ~$4.1M of DHR shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Danaher Corporation

For Danaher Corporation, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports and 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DHR page.

Other recent filings by Gregory M Milosevich, Executive Vice President

• SEC Form 4 at Danaher Corporation (DHR)Feb 20, 2026

The full history of Gregory M Milosevich, Executive Vice President is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Danaher Corporation

• SEC Form 144Nov 10, 2026
• SEC Form 4Nov 10, 2026
• SEC Form 144Nov 9, 2026
• SEC Form 144Nov 9, 2026
• SEC Form 144Nov 9, 2026
• SEC Schedule 13GNov 5, 2026

Everything OQRO holds on this company is on its DHR page.